Pangaea Oncology S.A. (PANG) — Cash Flow-to-Debt Ratio
Pangaea Oncology S.A. (PANG) has a Cash Flow-to-Debt Ratio of -0.15x as of June 2025, meaning its operating cash flow of €-1.26 Million could theoretically repay 0% of its total liabilities (€8.43 Million) in one year. Check PANG operating cash flow to net income to evaluate the quality of earnings relative to operating cash generation.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Pangaea Oncology S.A. Cash Flow-to-Debt Ratio (2013–2024)
Historical debt coverage capacity for Pangaea Oncology S.A. across 12 annual periods. Also explore Pangaea Oncology S.A. total assets for the complete picture of this company's asset base.
Annual Cash Flow-to-Debt Ratio for Pangaea Oncology S.A. (2013–2024)
Year-by-year debt coverage analysis for Pangaea Oncology S.A.. For market capitalisation and broader financial context, see PANG company net worth.
| Year | CF-to-Debt Ratio | Operating CF (EUR) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | -0.48x | €-4.57 Million | €9.57 Million | ▼ -99.5% |
| 2023 | -0.24x | €-2.40 Million | €10.03 Million | ▲ +65.5% |
| 2022 | -0.69x | €-3.68 Million | €5.30 Million | ▼ -87.6% |
| 2021 | -0.37x | €-2.50 Million | €6.76 Million | ▼ -66.1% |
| 2020 | -0.22x | €-1.92 Million | €8.61 Million | ▲ +20.5% |
| 2019 | -0.28x | €-2.40 Million | €8.56 Million | ▼ -51.7% |
| 2018 | -0.18x | €-2.17 Million | €11.74 Million | ▲ +60.4% |
| 2017 | -0.47x | €-6.48 Million | €13.91 Million | ▼ -211.4% |
| 2016 | -0.15x | €-1.78 Million | €11.89 Million | ▲ +35.5% |
| 2015 | -0.23x | €-2.31 Million | €9.95 Million | ▲ +16.2% |
| 2014 | -0.28x | €-1.89 Million | €6.83 Million | ▼ -97.8% |
| 2013 | -0.14x | €-659.69K | €4.71 Million | — |